2015
|
Invention
|
Cathepsin inhibitors.
The present invention is directed to inhibitors of cathepsins and the meth... |
2014
|
Invention
|
Processes and intermediates useful for preparing cysteine protease inhibitors. The present invent... |
|
Invention
|
Di-fluoro containing compounds as cysteine protease inhibitors.
The present invention is directe... |
|
Invention
|
Processes and intermediates for the preparation of 3 amino-n-cyclopropyl-2 hydroxypropionamide de... |
|
Invention
|
Cathepsin inhibitors. The present invention is directed to inhibitors of cathepsins and the metho... |
2012
|
Invention
|
Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system.
... |
|
Invention
|
Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system. T... |
|
Invention
|
Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain. The present invention... |
2010
|
Invention
|
Process for the preparation of (s)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl est... |
|
Invention
|
S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof. The ... |
2009
|
Invention
|
Haloalkyl containing compounds as cysteine protease inhibitors. The present invention is directed... |
|
Invention
|
Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives. The pr... |
|
Invention
|
Inhibitors of cathepsin b. The present invention is directed to a method of using compounds of Fo... |
2008
|
Invention
|
Substituted pyrazines that inhibit protease cathepsin s and hcv replication. The present inventio... |
|
Invention
|
Compounds that inhibit protease cathepsin s and hcv replication. The present invention is directe... |
|
Invention
|
Process for the preparation of (s)-2-(3-tert-butylureido)-3,3-dimethylbutanoic acid. (S)-2-(3-ter... |
|
Invention
|
Di-fluoro containing compounds as cysteine protease inhibitors. The present invention is directed... |
|
Invention
|
Hcv inhibitors. The present invention is directed to compounds that are antiviral agents. Specifi... |
|
Invention
|
Hcv inhibitors.
The present invention is directed to compounds that are antiviral agents. Specif... |
2007
|
Invention
|
Antiviral agents.
Compounds are provided having utility for the treatment of viral infections, p... |
|
Invention
|
Antiviral agents. Compounds are provided having utility for the treatment of viral infections, pa... |
2006
|
Invention
|
Antiviral agents. The present invention is directed to compounds that are antiviral agents. Speci... |
|
Invention
|
Antiviral agents.
The present invention is directed to compounds that are antiviral agents. Spec... |
|
Invention
|
Sulfonyl containing compounds as cysteine protease inhibitors. The present invention is directed ... |
2004
|
Invention
|
Haloalkyl containing compounds as cysteine protease inhibitors.
The present invention is directe... |
|
Invention
|
Haloalkyl containing compounds as cysteine protease inhibitors. The application is directed to ha... |
|
Invention
|
Amidino compounds as cysteine protease inhibitors. The present invention is directed to compounds... |